Outcomes of Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza

Submitted by: Christopher Anderson

Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2021.05.060

Keywords:

Author(s): Emily Shih, MD John J. Squiers, MD J. Michael DiMaio, MD Timothy George, MD Jasjit Banwait, PhD Kara Monday, MD Britton Blough, MD Dan Meyer, MD Gary S. Schwartz, MD

Extracorporeal membrane oxygenation (ECMO) can be effective for refractory acute respiratory distress syndrome (ARDS) in patients with influenza, but its utility in patients with coronavirus disease 2019 (COVID-19) is uncertain. We compared outcomes of patients with refractory ARDS from COVID-19 and influenza placed on ECMO.

Add Comments

ADD TO PLAYLIST

Related Content